Literature DB >> 11889426

Bronchiolitis obliterans organizing pneumonia in an orthotopic liver transplant patient.

Alan J DeAngelo1, Daniel Ouellette.   

Abstract

A 67-year-old woman was hospitalized for progressive dyspnea on exertion. She had undergone orthotopic liver transplantation (OLT) 15 months before admission. Posttransplant therapy consisted of tacrolimus, trimethoprim/sulfamethoxazole, and prednisone (the latter two were discontinued after 1 year). Physical examination revealed fine bibasilar crackles. High-resolution chest CT demonstrated bilateral, diffuse, interstitial infiltrates. Symptoms persisted on i.v. antibiotics and bronchoscopy was performed demonstrating patchy fibroplastic plugs within air spaces consistent with bronchiolitis obliterans organizing pneumonia (BOOP). Prednisone was initiated and the patient had an uneventful recovery. BOOP was initially described as an idiopathic disease process with clinical, radiographic, pathological, and prognostic features distinguishing it from bronchiolitis obliterans and idiopathic pulmonary fibrosis. BOOP has been recognized as a complication of lung and bone marrow transplantation, but the mechanism is unknown. We report a case of BOOP after OLT to highlight the risk in all transplant patients as well as the protective effect of posttransplant prednisone.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11889426     DOI: 10.1097/00007890-200202270-00009

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  2 in total

1.  Onset of bronchiolitis obliterans organizing pneumonia in a liver transplant recipient under peg-interferon and ribavirin treatment.

Authors:  Cristina Crespi; Silvia Gualandi; Fabio Piscaglia; Luigi Bolondi
Journal:  Intern Emerg Med       Date:  2008-02-07       Impact factor: 3.397

Review 2.  Cryptogenic organizing pneumonia.

Authors:  Jean-François Cordier
Journal:  Clin Chest Med       Date:  2004-12       Impact factor: 2.878

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.